Streetbeat News

Revenues

ERIE

FIS

GPN

LVS

MKTX

PLTR

PYPL

SPY

VTRS

WBD

WYNN

The article discusses the worst-performing S&P 500 stocks during Biden's first year in office and speculates on potential trends if Kamala Harris wins the 2024 election. It highlights the underperformance of financials and casino stocks in 2021 and suggests these sectors might continue to struggle under Democratic leadership.

Portfolio Pulse from Chris Katje

November 02, 2024 | 12:58 pm

LIVN

LivaNova announced that the Centers for Medicare & Medicaid Services (CMS) will maintain VNS Therapy for drug-resistant epilepsy (DRE) at Level 5 Ambulatory Payment Classification (APC) under the 2025 Medicare Hospital Outpatient Prospective Payment System. LivaNova will continue to seek reimbursement opportunities for this therapy.

Portfolio Pulse from Benzinga Newsdesk

November 01, 2024 | 10:48 pm

Chubb Limited (NYSE:CB) has announced estimated net losses due to Hurricane Milton, ranging from $250-300 million pre-tax and $208-250 million after-tax. These losses affect the company's commercial, personal property, casualty insurance, and reinsurance operations.

Portfolio Pulse from Benzinga Newsdesk

November 01, 2024 | 9:01 pm

AFL

Analysts have varied opinions on Aflac (NYSE:AFL), with recent ratings showing a mix of bullish, indifferent, and somewhat bearish sentiments. The average 12-month price target has increased by 9.16% to $103.92. Despite challenges in revenue growth and profitability, analysts have raised their price targets, indicating a positive outlook.

Portfolio Pulse from Benzinga Insights

November 01, 2024 | 9:00 pm

MBUU

Malibu Boats (NASDAQ: MBUU) has received mixed analyst ratings over the past three months, with a recent increase in average price targets. Analysts have varied opinions, ranging from 'Buy' to 'Neutral', with price targets between $42 and $50. Despite challenges in revenue growth and returns, Malibu Boats maintains a strong net margin and low debt-to-equity ratio.

Portfolio Pulse from Benzinga Insights

November 01, 2024 | 9:00 pm

EMN

Eastman Chemical (NYSE:EMN) has received mixed analyst ratings, with a neutral stance from four analysts. Recent price target increases suggest a positive outlook, with an average target of $114.25, up from $106.50. The company shows strong profitability and effective cost management, but its revenue growth lags behind industry peers.

Portfolio Pulse from Benzinga Insights

November 01, 2024 | 9:00 pm

CMS

Analysts have provided mixed ratings for CMS Energy over the past three months, with a recent increase in the average 12-month price target to $72.15. The company's financial performance shows strong revenue growth and net margins, but it faces challenges with high debt levels.

Portfolio Pulse from Benzinga Insights

November 01, 2024 | 9:00 pm

NUWE

Nuwellis, Inc. (NASDAQ:NUWE) announced preliminary Q3 2024 results, expecting $2.4M in revenue, a 28% growth in the pediatric category, a 70% gross margin, and a 30% reduction in operating costs. The company also terminated a license agreement with SeaStar Medical, receiving $900,000 in settlement.

Portfolio Pulse from Benzinga Newsdesk

November 01, 2024 | 8:17 pm

ODC

Oil-Dri Corporation of America (NYSE:ODC) announced price increases of 5% to 8% on its industrial, automotive, and sports field products, effective November 1, 2024. The price hikes aim to offset higher costs and support manufacturing infrastructure investments.

Portfolio Pulse from Benzinga Newsdesk

November 01, 2024 | 8:12 pm

HTCR

HeartCore Enterprises has corrected its announcement, projecting a 15% sales growth for its expanded flagship CMS platform.

Portfolio Pulse from Benzinga Newsdesk

November 01, 2024 | 8:11 pm